As of January 22, 2025, Prelude Therapeutics (PRLD) has a market cap of $64.391 million USD. According to our data, Prelude Therapeutics is ranked No.8012 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $64.39 M |
19.72%
|
Dec 31, 2024 | $53.79 M |
-70.14%
|
Dec 29, 2023 | $0.18 B |
-29.30%
|
Dec 30, 2022 | $0.25 B |
-51.49%
|
Dec 31, 2021 | $0.53 B |
-82.60%
|
Dec 31, 2020 | $3.02 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Zentalis Pharmaceuticals
ZNTL
|
$0.16 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Gossamer Bio
GOSS
|
$0.20 B |
0.000 M
|
USA
|
Repare Therapeutics
RPTX
|
$51.44 M |
0.000 M
|
Canada
|
Market Cap | = | PRLD Stock Price | * | PRLD Shares Outstanding |
= | $1.17 | * | 42.18 M | |
= | $64.39 M |